Portugal vs Upper-middle income (World Bank): Hypertension: effective treatment coverage (controlled hypertension)
Portugal
47.4%
in 2019
Upper-middle income (World Bank)
18.9%
in 2019
Portugal rank
6th
Upper-middle income (World Bank) rank
9th
Hypertension: effective treatment coverage (controlled hypertension) over time
- Portugal
- Upper-middle income (World Bank)
How they compare
Portugal currently reports 47.4% against 18.9% in Upper-middle income (World Bank), a difference of 28.5%.
That makes Portugal's figure about 2.5 times Upper-middle income (World Bank)'s.
Across all 30 years both countries report, Portugal has been ahead every year.
Portugal ranks 6th and Upper-middle income (World Bank) ranks 9th of 193 countries.
Portugal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Portugal | Upper-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 9.7% | 4.6% | 5.1% | Portugal |
| 2000s | 20.8% | 9.6% | 11.2% | Portugal |
| 2010s | 40.0% | 16.5% | 23.5% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), Portugal or Upper-middle income (World Bank)?
- Portugal, at 47.4% against 18.9% in Upper-middle income (World Bank) as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between Portugal and Upper-middle income (World Bank)?
- 28.5%, with Portugal ahead.
- How many years of comparable data are there for Portugal and Upper-middle income (World Bank)?
- 30 years are reported by both, from 1990 to 2019.
- How do Portugal and Upper-middle income (World Bank) rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- Portugal ranks 6th and Upper-middle income (World Bank) ranks 9th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.